Healthcare / Healthcare PlansUpdated 2026-05-10 22:07 UTC

CLOV stock hub

Clover Health Investments, Corp. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CLOVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CLOV

In the news

Latest news · CLOV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E31.9

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-16.9

P25 -105.6P50 -46.5P75 -3.1

ROIC-10.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CLOV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

USD

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001661101
Company name	Clover Health Investments, Corp.
Country	United States
Country code	US
Cusip	18914F103
Employees	724
Employees Change	154%
Employees Change Percent	27.02
Enterprise value	$1.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Healthcare Plans
Isin	US18914F1030
Last refreshed	2026-05-10
Market cap	$1.6B
Market cap category	Small-Cap
Price	$3.12
Price currency	USD
Rev Per Employee	3,052,991.71x
Sector	Healthcare
Sic	8090
Symbol	CLOV
Website	https://www.cloverhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.47%
EV Sales Forward	0.48x
EV/FCF	26.95x
EV/Sales	0.67x
FCF yield	3.32%
Forward P/E	31.92x
P/B ratio	4.83x
P/S ratio	0.74x
PS Forward	0.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-2.58%
EBITDA Margin	-2.56%
FCF margin	2.47%
Gross margin	18.36%
Gross Profit	$405.8M
Net Income	$-56.9M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-2.58%
Profit Margin	-2.58%
Profit Per Employee	$-78,648
ROA	-5.55
Roa5y	-23.26
ROCE	-15.76
ROE	-16.86
Roe5y	-95.53
ROIC	-10.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-17.25%
Cagr3y	56.74%
Cagr5y	-18.39%
EPS Growth Years	0
Revenue Growth	48.69x
Revenue Growth Q	62.05x
Revenue Growth Quarters	10x
Revenue Growth Years	3x
Revenue Growth3 Y	-9.57x
Revenue Growth5 Y	25.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$3.45
Assets	$697.7M
Cash	$203.5M
Equity	$339.4M
Liabilities	$358.3M
Net Cash	$173.3M
Net Cash By Market Cap	$10.54
Net Cash Growth	11.47%
Net Debt Equity	$-0.51
Net Debt FCF	$-3.18
Tangible Book Value	$336.4M
Tangible Book Value Per Share	$0.64
WACC	17.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.33
Net Working Capital	$-61.8M
Quick ratio	1.21
Working Capital	$111.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.19%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-17.24%
200-day SMA	2.52
3Y total return	285.19%
50-day SMA	2.14
50-day SMA vs 200-day SMA	50under200
5Y total return	-63.81%
All Time High	28.85
All Time High Change	-89.19%
All Time High Date	2021-06-09
All Time Low	0.61
All Time Low Change	414.85%
All Time Low Date	2024-04-22
ATR	0.15
Beta	2.45
Beta1y	1.96
Beta2y	1.61
Ch YTD	32.77
High	3.15
High52	3.92
High52 Date	2025-10-24
High52ch	-20.41%
Low	2.72
Low52	1.58
Low52 Date	2026-04-01
Low52ch	97.47%
Ma50ch	45.86%
Premarket Change Percent	-1.06
Premarket Price	$2.79
Premarket Volume	25,412
Price vs 200-day SMA	23.61%
RSI	80.19
RSI Monthly	53.75
RSI Weekly	63.77
Sharpe ratio	-0.01x
Sortino ratio	0.07
Total Return	-5.19%
Tr YTD	32.77
Tr1m	64.21%
Tr1w	15.13%
Tr3m	46.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Buy
Earnings EPS Estimate	$0.06
Earnings Revenue Estimate	713,475,152x
Earnings Revenue Estimate Growth	54.32x
Operating Income	$-56.9M
Operating margin	-2.58
Price target	$2.9
Price Target Change	$-7.05

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	407,939,031%
Float Percent	77.45%
Shares Insiders	21.87%
Shares Institutions	23.82%
Shares Out	526,684,324
Shares Qo Q	0.96%
Shares Yo Y	5.19%
Short Float	9.95%
Short Ratio	7.14
Short Shares	7.71

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-34.9M
Average Volume	5,768,263.35x
Bv Per Share	0.65
CAPEX	$-2.7M
Ch1m	64.21
Ch1w	15.13
Ch1y	-17.24
Ch3m	46.48
Ch3y	285.2
Ch5y	-63.81
Ch6m	16.85
Change	10.64%
Change From Open	11.03
Close	2.82
Days Gap	-0.35
Dollar Volume	32,412,032.6
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$-56.9M
EBITDA	$-56.7M
EPS	$-0.11
F Score	3
FCF	$54.5M
FCF EV Yield	3.71x
FCF Per Share	$0.1
Financing CF	-29,506,000
Fiscal Year End	December
Founded	2,014
Investing CF	-9,922,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Ma150	2.43
Ma150ch	28.34%
Ma20	2.48
Ma20ch	25.81%
Net CF	17,826,000
Next Earnings Date	2026-08-04
Open	2.81
Optionable	Yes
P FCF Ratio	30.13
P OCF Ratio	28.7
Position In Range	94.12
Post Close	3.12
Postmarket Change Percent	-0.64
Postmarket Price	$3.1
Ppne	6,904,000
Pre Close	2.82
Price Date	2026-05-08
Ptbv Ratio	4.88
Relative Volume	1.8x
Revenue	2,210,366,000x
SBC By Revenue	4.05x
Share Based Comp	89,491,000
Tr6m	16.85%
Us State	Delaware
Volume	10,388,472

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CLOV pay a dividend?

Capital-return profile for this ticker.

Performance

CLOV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CLOV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+23.8%

Float: +77.5% of shares outstanding

Insider ownership

+21.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CLOV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

80.2

Above 70: short-term overbought

Price vs 200-day MA

+23.6%

50/200-day relationship not available

Beta (5Y)

2.45

More volatile than the market

Sharpe ratio

-0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CLOV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CLOV stock rating?

Clover Health Investments, Corp. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CLOV analysis?

The full report lives at /stocks/CLOV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CLOV?

The latest report frames CLOV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CLOV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.